Pharmacy Times
MAY 19, 2025
The Lumipulse G pTau217/-Amyloid 1-42 Plasma Ratio is the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
STAT
MAY 19, 2025
Molecular biologist Chiara Masnovo spent weeks filling out an application for a research fellowship earlier this year — taking it over the finish line as she was 38 weeks pregnant and starting a new job. The chance of getting this fellowship was well worth the toil. The Hanna Gray fellowship, created by the Howard Hughes Medical institute, supports postdoctoral researchers from diverse backgrounds in their transition to heading their own labs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
MAY 19, 2025
The authors believe the results may serve as a foundation for hepatitis D virus (HDV) testing among hepatitis B virus surface antigen (HBsAg)-positive specimens.
STAT
MAY 19, 2025
This is the online version of STAT’s email newsletter Health Care Inc., delivered to your inbox every Monday. Sign up here. I’ve always been skeptical of virtual reality headsets, and it appears my skepticism has been justified. Tell me what’s going on in your reality, virtually: bob.herman@statnews.com or bobjherman.09 on Signal.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
MAY 19, 2025
COVID-19 can reshape ones academic journey and outlook on life.
pharmaphorum
MAY 19, 2025
The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
MAY 19, 2025
DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal
The FDA Law Blog
MAY 19, 2025
By Larry K. Houck Last month the U.S. Attorneys Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve allegations that its pharmacies illegally filled millions of invalid prescriptions for opioids and other controlled substances in violation of the federal Controlled Substances Act, and sought payment for filling many of those prescriptions by federal health care programs, violating the False Claims Act.
Pharmacy Times
MAY 19, 2025
The vaccine, indicated with a restriction on use for those younger than 65 years and without comorbidities, was proven safe and effective in a series of large clinical trials, and marks the first protein-based vaccine to be approved in the United States.
Pharmafile
MAY 19, 2025
The US Food and Drug Administration (FDA) has approved Roches VENTANA MET (SP44) RxDx Assay as a diagnostic tool to identify non-squamous non-small cell lung cancer (NSQ-NSCLC) patients eligible for treatment with AbbVies targeted therapy Emrelis (telisotuzumab vedotin-tllv). The assessment detects an overexpression of the MET protein, a predictive biomarker associated with tumour progression and […] The post FDA approves diagnostic tool for MET-targeted lung cancer therapy appeared first
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
MAY 19, 2025
Panelists discuss how health care teams can ensure patients remain on optimal low-density lipoprotein cholesterol (LDL-C)lowering therapy by leveraging collaborative strategies, facilitating therapy intensification, and incorporating essential components into shared decision-making tools to personalize treatment plans.
The Guardian - Pharmaceutical Industry
MAY 19, 2025
Drugmaker Regeneron Pharmaceuticals will buy the genetic testing firm through a bankruptcy auction The drugmaker Regeneron Pharmaceuticals will buy the genetic testing firm 23andMe Holding for $256m through a bankruptcy auction, the companies said on Monday. Regeneron said it will comply with 23andMes privacy policies and applicable laws with respect to the use of customer data and that it is ready to detail its intended use of the data to a court-appointed overseer.
Pharmacy Times
MAY 19, 2025
A study reveals sasanlimab enhances event-free survival in high-risk bladder cancer patients, offering new hope against disease recurrence.
Fierce Healthcare
MAY 19, 2025
Vertical consolidation in healthcare has been a hot-button topic of late as regulators eye strategies to bring down healthcare costs.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MAY 19, 2025
Panelists discuss how medical professionals consider PCSK9 inhibitors, bempedoic acid, and inclisiran in various clinical scenarios, their experiences with these newer therapies, the implications of the INCEPTION trial for treating patients with high-risk cardiovascular diseaseparticularly those who are statin-intolerantthe urgency of postcoronary event treatment, and emerging data on the broader impact of low-density lipoprotein cholesterol (LDL-C)lowering therapies on quality of life.
Pharmafile
MAY 19, 2025
A breakthrough in lung therapy has been reported by German biotech company Viromed Medical whose cold plasma treatment has demonstrated 100% effectiveness against methicillin-resistant Staphylococcus aureus (MRSA), a common cause of ventilator-associated pneumonia (VAP). In an in vitro study led by Hortense Slevogt at Hannover Medical School and the Helmholtz Centre for Infection Research, Germany, […] The post Cold plasma therapy shown to be 100% effective against pneumonia-causing bacter
Pharmacy Times
MAY 19, 2025
A panelist discusses how physicians can collaborate with pharmacists to share patient information, coordinate vaccine schedules, and reinforce recommendations, while utilizing resources such as CDC guidelines, patient brochures, and digital tools to provide clear, evidence-based education on RSV prevention and vaccination.
Pharmaceutical Technology
MAY 19, 2025
Novo Nordisk stated that replacing Jrgensen is "in the best interests of the company and its shareholders"
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
MAY 19, 2025
New research highlights the effectiveness and safety of RSV vaccines for older adults, revealing critical insights into vaccination benefits and risks.
pharmaphorum
MAY 19, 2025
Weve seen recent tariff policy changes creating an increasingly volatile environment for exporters and importers alike, particularly those in the medical device and IVD sectors.
Pharmacy Times
MAY 19, 2025
Pharmacists should continue to emphasize the vaccines effectiveness in preventing cancer and be prepared to address patient safety concerns.
Pharmaceutical Technology
MAY 19, 2025
Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.
Pharmacy Times
MAY 19, 2025
Patients should understand that routine skin care is an important facet in the overall management of diabetes.
Fierce Healthcare
MAY 19, 2025
The nonprofit health system is behind the pace of its prior fiscal year across nine months, but has notched smaller and smaller operating losses since last spring's major cybersecurity incident.
Pharmacy Times
MAY 19, 2025
Pharmacists compare real-world practice data with clinical trial results and discuss supportive care options for patients.
Pharmaceutical Technology
MAY 19, 2025
In April 2025, the European Medicines Agency (EMA) approved Eisai and Biogens Leqembi for early-stage Alzheimers disease, marking Europes first major nod for a disease-modifying Alzheimers therapy in over a decade.
PharmExec
MAY 19, 2025
Leandro Boer, MD, PhD, VP, US general medicines, Amgen, explains why seamless communication and treatment continuity across primary care, cardiology, and rehabilitation are critical to improving outcomes and preventing care gaps for cardiovascular patients.
Pharmaceutical Technology
MAY 19, 2025
Explore Novotech CEO John Moller's insights on the company's global expansion, commitment to diversity, and innovative approaches in clinical research. Discover how Novotech is shaping the future of clinical trials with a focus on inclusivity and technological advancement.
Pharmaceutical Commerce
MAY 19, 2025
The partnership is centered around cutting cold chain costs and emissions with smart packaging and carbon-neutral same-day delivery.
pharmaphorum
MAY 19, 2025
The partner of disgraced ex-Theranos CEO Elizabeth Holmes, Billy Evans, has reportedly raised millions of dollars for another blood testing startup
PharmExec
MAY 19, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
European Pharmaceutical Review
MAY 19, 2025
With emerging technology innovations and current market challenges such as supply chain uncertainty, the cell and gene therapy sector is set to witness major shifts in the next decade and beyond. Stay up to date with the latest advances on cell and gene therapy, including articles on: Key trends and developments in the current cell and gene therapy sector Implementation of PAT for development of cell and gene therapies Navigating manufacturing bottlenecks in cell therapy, quality-related challen
Pharmaceutical Commerce
MAY 19, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Expert insights. Personalized for you.
143 
Let's personalize your content